Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $1.94 | Prev. Close $2.02 | Circuit Range N/A |
Day Range $1.83 - $1.94 | Year Range $0.97 - $17.09 | Volume 911 |
Average Traded $1.87 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-Apr-26 | $1.89 | $2.01 | +2.50% |
06-Apr-26 | $2.06 | $1.96 | -3.92% |
02-Apr-26 | $2.04 | $2.04 | -1.92% |
01-Apr-26 | $2.02 | $2.08 | +6.12% |
31-Mar-26 | $1.84 | $1.96 | +13.95% |
30-Mar-26 | $1.92 | $1.72 | -11.79% |
27-Mar-26 | $1.88 | $1.95 | +3.45% |